Two metabolites reduced in COPD patients are cofactors of carbamoyl phosphate synthetase I, the first enzyme in the urea cycle, the native cofactor, N-acetylglutamate and its structural analogue, N-carbamoylglutamate. Here, CPS1 is linked to chronic obstructive pulmonary disease.